Cancer Genomic Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cancer Genomic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Breast Cancer Genomic Testing
Lung Cancer Genomic Testing
Blood Cancer Genomic Testing
Liver Cancer Genomic Testing
Stomach Cancer Genomic Testing
Others
Segment by Application
Hospitals
Clinics
Diagnostic Laboratories
Academic and Research Institutes
Others
By Company
Myriad Genetics
Centogene AG
Color Genomics
Quest Diagnostics
23andMe Inc.
Gene By Gene Ltd.
LabCorp
Positive Bioscience
Bio-Rad Laboratories
Illumina, Inc.
Agilent Technologies
Thermo Fisher Scientific
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
